News & Updates

Voriconazole safe, effective in leukaemic patients with fungal infections

20 Jun 2020

Prophylaxis treatment with voriconazole appears to be safe and effective, with an efficacy comparable to literature data for risk of invasive fungal infection with posaconazole antifungal prophylaxis, in patients with acute leukaemia undergoing chemotherapy, reports a study.

Voriconazole safe, effective in leukaemic patients with fungal infections

20 Jun 2020

Dupilumab effective for chronic nodular prurigo

20 Jun 2020

Dupilumab is effective for reducing itch and improving skin lesions in patients with chronic nodular prurigo, a new study has found.

Dupilumab effective for chronic nodular prurigo

20 Jun 2020

Dupilumab improves symptoms, quality of life of patients with chronic nodular prurigo

19 Jun 2020

Use of dupilumab helps reduce itch and improve chronic nodular prurigo (CNPG) skin lesions, a recent study has shown.

Dupilumab improves symptoms, quality of life of patients with chronic nodular prurigo

19 Jun 2020

Delayed adverse events uncommon after injection with hyaluronic acid fillers

18 Jun 2020

Delayed adverse events (DAEs) associated with hyaluronic acid fillers (HA-Vs) appear to be relatively rare, a new study reports.

Delayed adverse events uncommon after injection with hyaluronic acid fillers

18 Jun 2020

Apremilast effective for scalp psoriasis

17 Jun 2020

Apremilast is an effective treatment option for moderate-to-severe psoriasis of the scalp, a new trial has found.

Apremilast effective for scalp psoriasis

17 Jun 2020

Dupilumab shows promise in bullous pemphigoid

17 Jun 2020

Use of dupilumab appears to confer benefits in patients with bullous pemphigoid (BP), results of a recent study have shown. Treatment has resulted in disease clearance or satisfactory response in majority of the patients, including those in whom previous conventional therapy has failed.

Dupilumab shows promise in bullous pemphigoid

17 Jun 2020

Apremilast proven effective in severe scalp psoriasis

16 Jun 2020 by

Apremilast proven effective in severe scalp psoriasis

16 Jun 2020

Infection risk comparable between biologics, nonbiologics in children with psoriasis

04 Jun 2020

No substantial difference in infection risk is seen between biologics and nonbiologics among children with psoriasis, reveals a recent study. There is also no robust difference between systemic treatment and phototherapy.